CDIOW — Cardio Diagnostics Holdings, Inc.

Nasdaq · Health Care · Life Sciences Tools & Services · CIK 1870144 ·
Last close
$0.02
Market Cap
52W High
$0.02
52W Low
$0.01
ADV30
4,249
Next earnings
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 2,680 -1,784,837 -1,788,158 9,559,371 7,077,021 655,972
Dec 2025 3,555 -1,463,222 -1,465,368 7,766,415 5,110,630 793,061
Sep 2025 2,855 -1,711,597 -1,714,536 8,788,902 6,355,218 637,331
Jun 2025 7,475 -1,678,699 -1,683,199 10,396,547 7,966,500 671,848

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-5,888,944
Investing CF
$-435,591
Financing CF
$3,712,837
CapEx
$-435,591
Dividends Paid
Buybacks
EPS Diluted TTM
As of
2026-06-07

Balance + Analyst (yfinance extras)

Retained Earnings
$-31,038,158
Inventory
Receivables
$4,274
ST Investments
EBIT TTM
$-6,637,712
Pretax Income TTM
$-6,651,261
Interest Exp TTM
$13,549
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$16,565
EBITDA
$-6,270,895
Free Cash Flow
$-3,927,246
Enterprise Value
Total Cash
$7,077,021
Total Debt
$533,002
Shares Out
Trailing EPS
Book Value
$3.01
ROE
-65.6%
ROA
-38.0%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 14,825 -6,484,078 -6,498,167 7,766,415 793,061 -5,726,833
Dec 2024 34,890 -8,365,877 -8,383,453 10,615,312 1,057,524 -4,993,104
Dec 2023 17,065 -7,242,459 -8,376,834 4,462,365 1,504,241 -5,672,175
Dec 2022 950 -4,548,451 -4,660,985 6,249,478 1,947,770 -5,090,968

Peers — same industry

TickerNameMarket CapLastDaily %
IDXX IDEXX LABORATORIES INC /DE $44.46B $563.57
IQV IQVIA HOLDINGS INC. $34.69B $207.85
INCY INCYTE CORP $23.32B $116.71
MEDP Medpace Holdings, Inc. $15.37B $538.23
ICLR ICON PLC $12.94B $167.72

News headlines (Yahoo Finance, 1h cache)

Cardio Diagnostics Holdings (CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans
2026-07-01 18:00 · Yahoo
Cardio Diagnostics Holdings (CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks
2026-06-30 18:30 · Yahoo
Cardio Diagnostics Holdings (CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection
2026-06-29 19:00 · Yahoo
Cardio Diagnostics Holdings (CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians
2026-06-25 15:19 · Yahoo
Atlas Healthcare Physicians to Cover Cardio Diagnostics’ Precision Cardiovascular Medicine Tests Across Its Network
2026-06-24 12:35 · Yahoo
Cardio Diagnostics Holdings (CDIO) Targets a $393B Heart Disease Problem With Epigenetics and AI
2026-06-23 19:10 · Yahoo
Cardio Diagnostics Holdings (CDIO) Aligns With Growing Shift Toward Predictive, Precision Medicine
2026-06-18 19:30 · Yahoo
Cardio Diagnostics Holdings (CDIO) Working to Help Employers Tackle Cardiovascular Risk, Healthcare Costs
2026-06-17 19:00 · Yahoo
Cardio Diagnostics (CDIO) Harnesses AI, Genetics and Epigenetics to Advance Cardiovascular Risk Detection
2026-06-15 18:15 · Yahoo
Cardio Diagnostics Holdings (CDIO) Showcases AI-Powered Cardiovascular Risk Solutions at Four National Benefits Conferences
2026-05-27 19:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.